Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection.

Sulpice L, Rayar M, Boucher E, Pele F, Pracht M, Meunier B, Boudjema K.

J Surg Res. 2013 Mar;180(1):56-61. doi: 10.1016/j.jss.2012.10.051. Epub 2012 Nov 20.

PMID:
23183056
2.

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.

Cancer. 2012 Oct 1;118(19):4737-47. doi: 10.1002/cncr.27492. Epub 2012 Mar 13.

3.

Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.

PMID:
11995440
4.

The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.

Yamashita Y, Taketomi A, Morita K, Fukuhara T, Ueda S, Sanefuji K, Iguchi T, Kayashima H, Sugimachi K, Maehara Y.

Anticancer Res. 2008 Jul-Aug;28(4C):2353-9.

5.

Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival.

Saxena A, Chua TC, Chu FC, Morris DL.

Am J Surg. 2011 Sep;202(3):310-20. doi: 10.1016/j.amjsurg.2010.08.041.

PMID:
21871986
6.

Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2009 Mar;16(3):623-9. doi: 10.1245/s10434-008-0278-3. Epub 2009 Jan 6.

PMID:
19130133
7.

Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y.

Ann Surg Oncol. 2010 Jul;17(7):1816-22. doi: 10.1245/s10434-010-0929-z. Epub 2010 Feb 5.

PMID:
20135355
8.

Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.

Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.

Hepatogastroenterology. 2007 Mar;54(74):346-9.

PMID:
17523271
9.
10.

Intrahepatic cholangiocarcinoma in Korea.

Kim HJ, Yun SS, Jung KH, Kwun WH, Choi JH.

J Hepatobiliary Pancreat Surg. 1999;6(2):142-8.

PMID:
10398901
11.

Survival analysis of intrahepatic cholangiocarcinoma after resection.

Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW, Lee SA, Hong EK, Lee WJ, Woo SM.

Ann Surg Oncol. 2010 Jul;17(7):1823-30. doi: 10.1245/s10434-010-0938-y. Epub 2010 Feb 18.

PMID:
20165987
12.

Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.

Li SQ, Liang LJ, Hua YP, Peng BG, He Q, Lu MD, Chen D.

Chin Med J (Engl). 2009 Oct 5;122(19):2286-91.

PMID:
20079127
13.

Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.

Jiang BG, Sun LL, Yu WL, Tang ZH, Zong M, Zhang YJ.

Cancer J. 2009 May-Jun;15(3):257-61. doi: 10.1097/PPO.0b013e31819e3312.

PMID:
19556914
14.

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR.

Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3.

PMID:
18580211
15.

Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.

Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F.

Ann Surg Oncol. 2009 Feb;16(2):404-12. doi: 10.1245/s10434-008-0227-1. Epub 2008 Nov 27.

PMID:
19037702
16.

Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.

Chu KJ, Lu CD, Dong H, Fu XH, Zhang HW, Yao XP.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):192-9. doi: 10.1097/MEG.0b013e3283625df9.

PMID:
24370644
17.

Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.

Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T.

Ann Surg Oncol. 2008 Feb;15(2):590-9. Epub 2007 Dec 5.

PMID:
18057991
18.

An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.

Tajima Y, Kuroki T, Fukuda K, Tsuneoka N, Furui J, Kanematsu T.

Br J Surg. 2004 Jan;91(1):99-104.

PMID:
14716802
19.

Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases.

Zhu HF, Li J, Huang L, Yan YQ.

Hepatogastroenterology. 2013 Mar-Apr;60(122):263-7. doi: 10.5754/hge12711.

PMID:
23574653
20.

Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.

Saiura A, Yamamoto J, Kokudo N, Koga R, Seki M, Hiki N, Yamada K, Natori T, Yamaguchi T.

Am J Surg. 2011 Feb;201(2):203-8. doi: 10.1016/j.amjsurg.2008.12.035. Epub 2009 May 9.

PMID:
19427630

Supplemental Content

Support Center